New Blood-Saving technique could transform liver surgery
NCT ID NCT07629648
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a controlled blood removal method during liver surgery to see if it lowers the need for blood transfusions. About 60 adults having liver resection for cancer will take part. The approach involves removing a small amount of blood before surgery and giving it back afterward, along with careful monitoring and standardized care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hypovolemic phlebotomy (controlled blood removal and reinfusion)
What this could lead to
If successful, this could reduce the need for blood transfusions during liver surgery, leading to fewer complications and faster recovery.
What could go wrong
This is a small, early-stage quality improvement project with only 60 participants. The approach may not work for all patients or may carry risks like unstable blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact